AdvertisementAdvertise with NZME.
Stock Takes
Stock Takes: Rain not enough to stop dry weather from hurting NZ power company earnings
Mercury, Meridian and Manawa are likely to be hit hardest by the earlier drought.
Spark auctioning half its data centre business to fund $1b expansion push: report
Surf's up for the telco as its capital-raising effort comes to the sharp end.
Stock Takes: Is gold a good bet?
Gold has hit a record high this week but is it a good investment?
Stock Takes: Focus turns to second half after RBNZ rate cut
Focus has turned to those companies who will benefit from this week's RBNZ rate cut.
Stock Takes: Will NZ corporate earnings offer green shoots for the economy?
The reporting season gets fully underway next week. Will there be green shoots?
Stock Takes: Why the NZ sharemarket is lagging the rest
There are some stark contrasts between the local index and other comparable markets.
Stock Takes: The big issues facing F&P Healthcare
F&P Healthcare's share price has held despite concerns about the US health sector.
Stock Takes: Why a2 is out of favour, and a role reversal for Fonterra
Private equity is seen as a likely buyer for Fonterra's consumer business.
'Money for jam': How much bankers made from Auckland Airport’s whopper capital raise
Plus: Sky TV gets a thumbs-up for its deal-making skills.
Stock Takes: Why a $4 billion deal fell over
The failed Ebos deal would have been a big bite for investors.
Stock Takes: NZ Shareholders Association on seeing the wood for the trees
The NZSA has questioned the timeliness of PGW's disclosure.
Is this tech company the next Xero?
This freshly listed tech start-up is back by Sir Owen Glenn.
'NZ is in a tough patch': Why our economy is looking like the US during the GFC
Fisher Funds' Ashley Gardyne weighs in on how markets have performed.
Why is there such a dearth of companies listing on the NZX?
It has been months since the last listing on the NZ Stock Exchange.
How this NZ pharma firm prices drugs to avoid villain status
This NZ drug maker says it puts health above wealth.
No easy fix for high inflation environment
Fisher Funds portfolio manager Matt Peek talks about the impact of the Budget.
A capital raise for Synlait - or something more radical for balance sheet woes?
Stock Takes: Is the underperforming Synlait Milk heading toward another capital raise?
‘A rounding error’: Why Govt’s $4b Budget boost doesn’t signal big spend-up
The no-frills Budget needs to focus on the basics.
Is it time to list Ports of Auckland on share market?
A new report has highlighted some problems with local government ownership.